Dark

SMMT
Summit Therapeutics Inc. Common Stock
stock NASDAQ

At Close

Jun 18, 2025 3:59:48 PM EDT

20.17USD+1.612%(+0.32)2,746,663

20.15Bid 20.20Ask 0.05Spread

Pre-market

Jun 18, 2025 9:08:30 AM EDT

19.85USD0.000%(0.00)2,806

After-hours

Jun 18, 2025 4:53:30 PM EDT

20.16USD-0.050%(-0.01)228,791

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

14.98B

Headquarters

OXFORDSHIRE, GBR

Industry

Biotechnology

Next Earnings

Oct 28, 2025 (132d)

SRPT ACER XLV

SMMT Stats

Avg. Vol. 10 Day

3,852,633

Avg. Vol. 30 Day

4,335,531

Employees

Market Cap

14,979,571,687

Shares Out.

742,665,924

On/Off Exchange

54%/46%

6 Month Beta

1.50

1 Year Beta

1.76

2 Year Beta

1.31

3 Year Beta

0.49

52 Week Low

6.78

52 Week High

36.91

SMA50

23.44

SMA200

20.76

1 Week

+3.01%

1 Month

-15.99%

3 Month

+1.72%

6 Month

+18.79%

1 Year

+154.03%

2 Year

+719.92%

5 Year

+522.53%

Profile

summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. difficile.

SMMT Stock Summary

Summit Therapeutics Inc. Common Stock (NASDAQ:SMMT) stock price today is $20.17, and today's volume is 2,746,663. SMMT is up 1.612% today. The 30 day average volume is 4,335,531. SMMT market cap is 14.98B with 742,665,924 shares outstanding.